A Long-term Follow-up Study in Patients Who Received BEAM-101

Recruiting now

Conditions studied: Hemoglobinopathy, Sickle Cell Disease

In brief

This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to participate in this LTFU study prior to completing Study BTX-AUT-001. Patients who enter into this study will be followed for 13 years (a total of 15 years after receiving BEAM-101).

Key facts

Study ID
NCT07373639
Run by
Beam Therapeutics Inc.
People needed
50
Starts
2025-12-15
Expected to finish
2043-02-12
Last updated by the study team
2026-01-28

Who can join

Age: 14 and older, up to 37. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.